Wang, Chunyan
van Haperen, Rien
Gutiérrez-Álvarez, Javier http://orcid.org/0000-0003-0690-9496
Li, Wentao http://orcid.org/0000-0002-7114-762X
Okba, Nisreen M. A. http://orcid.org/0000-0002-2394-1079
Albulescu, Irina
Widjaja, Ivy
van Dieren, Brenda
Fernandez-Delgado, Raul http://orcid.org/0000-0001-7411-9010
Sola, Isabel http://orcid.org/0000-0002-5704-1917
Hurdiss, Daniel L. http://orcid.org/0000-0003-3834-5808
Daramola, Olalekan
Grosveld, Frank
van Kuppeveld, Frank J. M. http://orcid.org/0000-0001-5800-749X
Haagmans, Bart L. http://orcid.org/0000-0001-6221-2015
Enjuanes, Luis
Drabek, Dubravka http://orcid.org/0000-0002-9781-1701
Bosch, Berend-Jan http://orcid.org/0000-0002-3864-232X
Article History
Received: 20 October 2020
Accepted: 15 February 2021
First Online: 17 March 2021
Competing interests
: C.W., R.v.H., W.L., I.W., B.v.D., N.M.A.O., F.G., F.J.M.v.K., B.L.H., D.D., and B.J.B. are inventors on a patent application on monoclonal antibodies targeting MERS-CoV (patent publication no.: WO/2020/169755). F.G., D.D. and R.H. are non-substantial interest shareholders in Harbour Biomed and were part of the team that generated the mice. The other authors declare no competing interests.